NABOTA®
FDA, EMA, TİTCK ve HEALTH CANADA ONAYLI
FDA onaylı botulinum toksin
GLOBAL KLİNİK ÇALIŞMALAR
Amerika, Kanada ve Avrupa’da 2000’in üzerinde hasta
HI PURE PATENTLİ TEKNOLOJİ
Patentli saflaştırma teknolojisi
Daha yüksek saflıkta 900 kDa botulinum toksin
Referanslar:
1- FDA Approval Letter, 01.02.2019 (https://www.accessdata.fda.gov/drugsatfda|_- docs/nda/2019/761085Orig1s000TOC.cfm).EMA approval, 27.09.2019(https://www.ema.europa. eu/en/medicines/human/EPAR/nuceiva#authorisationdetails-selection) Health Canada approval, 16.08.2018 https:// health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97069.
2- Beer K, et al. Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies. Dermatologic Surgery. 2019;45(11):1381-139
3- The United States Patent and Trademark Office; Registration no.9,512,418